Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Privia Health
PRVA
$3.02B
| $628K | ﹤0.01% |
22,739
-4,029
| -15% | -$106K |
|
|
DCH
552
Dauch Corp
DCH
$1.42B
| $626K | ﹤0.01% |
+80,212
| New | +$688K |
|
553
Dorian LPG
LPG
$1.84B
| $625K | ﹤0.01% |
31,334
-18,892
| -38% | -$384K |
|
554
Crocs
CROX
$6.58B
| $616K | ﹤0.01% |
+4,874
| New | +$589K |
|
555
American Well
AMWL
$218M
| $614K | ﹤0.01% |
13,006
-546
| -4% | -$35K |
|
556
Sprouts Farmers Market
SFM
$7.94B
| $605K | ﹤0.01% |
17,271
-1,902
| -10% | -$61.5K |
|
557
United Bankshares
UBSI
$6.72B
| $593K | ﹤0.01% |
16,851
-3,101
| -16% | -$122K |
|
558
BellRing Brands
BRBR
$1.47B
| $587K | ﹤0.01% |
+17,260
| New | +$510K |
|
|
AXON
559
Axon Enterprise
AXON
$49.1B
| $586K | ﹤0.01% |
2,607
+513
| +24% | +$102K |
|
560
Waste Management
WM
$89.7B
| $558K | ﹤0.01% |
3,418
-770
| -18% | -$118K |
|
561
Vishay Intertechnology
VSH
$5.09B
| $548K | ﹤0.01% |
+24,212
| New | +$532K |
|
|
ISEE
562
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $542K | ﹤0.01% |
+22,268
| New | +$488K |
|
563
MongoDB
MDB
$30.3B
| $458K | ﹤0.01% |
1,966
-2,106
| -52% | -$442K |
|
564
SIGA Technologies
SIGA
$226M
| $455K | ﹤0.01% |
+79,111
| New | +$529K |
|
|
ANSS
565
DELISTED
Ansys
ANSS
| $454K | ﹤0.01% |
+1,364
| New | +$385K |
|
566
Flywire
FLYW
$2.3B
| $423K | ﹤0.01% |
14,413
-2,349
| -14% | -$61.9K |
|
567
Toro Company
TTC
$9.42B
| $423K | ﹤0.01% |
3,805
+305
| +9% | +$34K |
|
|
NVMI
568
Nova
NVMI
$12.8B
| $394K | ﹤0.01% |
+3,773
| New | +$353K |
|
569
Crown Castle
CCI
$32.3B
| $374K | ﹤0.01% |
2,792
| – | – |
|
570
Transmedics
TMDX
$2.64B
| $325K | ﹤0.01% |
+4,288
| New | +$297K |
|
571
Planet Fitness
PLNT
$4.48B
| $284K | ﹤0.01% |
+3,661
| New | +$292K |
|
572
Fox Factory Holding Corp
FOXF
$824M
| $284K | ﹤0.01% |
+2,342
| New | +$269K |
|
573
XPEL
XPEL
$1.39B
| $274K | ﹤0.01% |
+4,034
| New | +$285K |
|
574
Equinor
EQNR
$90.6B
| $273K | ﹤0.01% |
9,610
+1,217
| +15% | +$36.7K |
|
575
Phillips 66
PSX
$81.2B
| $266K | ﹤0.01% |
2,622
-904
| -26% | -$91.9K |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.